Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Randomized Crossover Manometry Study of Prucalopride vs PEG 3350 + Electrolytes in Chronic Constipation
2012-002495-13Phase 4Completed
- Sponsor
- Movetis
- Start
- Oct 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of prucalopride and polyethylene glycol in chronic constipation (2 arms), sponsored by Movetis. Primary endpoint: Number of HAPCs during 12 hours after treatment initiation. Started Oct 2012; status: completed.
02
Drugs
prucalopridepolyethylene glycol
03
Conditions
chronic constipation
Beyond the preview
Go deeper on 2012-002495-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002495-13.